This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antimicrobial Resistance
November 2, 2022 | 1-Day Digital Conference
Digital Conference8:00AM EST // 12:00PM GMT // 1:00PM CET
Menu

Bruce Altevogt
VP and Head External Medical Engagement, Hospital Business Unit at Pfizer, USA
Speaker

Profile

Bruce Altevogt is Vice President and Head External Medical Engagement, responsible for establishing and managing patient and medical stakeholder engagement strategy for antimicrobial resistance (AMR) and COVID-19. In addition, his team leads Pfizer’s antimicrobial stewardship strategy, including management of the industry leading AMR surveillance program, ATLAS.

Dr. Altevogt serves as a member of the Boards for Healthcare Ready and the AMR Industry Alliance Board.

Prior to joining Pfizer Inc. Dr. Altevogt served as a senior program officer on the Board on Health Sciences Policy at the National Academy of Medicine

Dr. Altevogt received a doctorate from Harvard University’s Program in Neuroscience and a B.A. from the University of Virginia.

Agenda Sessions

  • Data for Action: Driving change in how we address AMR

    , 09:15
    View Session

At this event

Prev
Next
Avisha Amalean
Digital Events Conference Producer
Informa Connect, UK

See Bruce at Antimicrobial Resistance